Literature DB >> 31669733

Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways.

Zhiyun Wei1, Xingjun Meng2, Rachid El Fatimy3, Bowen Sun3, Dongmei Mai2, Junfang Zhang4, Ramil Arora3, Ailiang Zeng3, Pingyi Xu5, Shaogang Qu2, Anna M Krichevsky3, Dennis J Selkoe3, Shaomin Li6.   

Abstract

As the most common cause of progressive cognitive decline in humans, Alzheimer's disease (AD) has been intensively studied, but the mechanisms underlying its profound synaptic dysfunction remain unclear. Here we confirm that exposing wild-type mice to an enriched environment (EE) facilitates signaling in the hippocampus that promotes long-term potentiation (LTP). Exposing the hippocampus of mice kept in standard housing to soluble Aβ oligomers impairs LTP, but EE can fully prevent this. Mechanistically, the key molecular features of the EE benefit are an upregulation of miRNA-132 and an inhibition of histone deacetylase (HDAC) signaling. Specifically, soluble Aβ oligomers decreased miR-132 expression and increased HDAC3 levels in cultured primary neurons. Further, we provide evidence that HDAC3 is a direct target of miR-132. Overexpressing miR-132 or injecting an HDAC3 inhibitor into mice in standard housing mimics the benefits of EE in enhancing hippocampal LTP and preventing hippocampal impairment by Aβ oligomers in vivo. We conclude that EE enhances hippocampal synaptic plasticity by upregulating miRNA-132 and reducing HDAC3 signaling in a way that counteracts the synaptotoxicity of human Aβ oligomers. Our findings provide a rationale for prolonged exposure to cognitive novelty and/or epigenetic modulation to lessen the progressive effects of Aβ accumulation during human brain aging.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31669733      PMCID: PMC7243177          DOI: 10.1016/j.nbd.2019.104617

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  76 in total

Review 1.  microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  FASEB J       Date:  2017-02       Impact factor: 5.191

2.  A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins.

Authors:  Shivendra Kishore; Lukasz Jaskiewicz; Lukas Burger; Jean Hausser; Mohsen Khorshid; Mihaela Zavolan
Journal:  Nat Methods       Date:  2011-05-15       Impact factor: 28.547

3.  Amyloid-beta peptide decreases expression and function of glutamate transporters in nervous system cells.

Authors:  Huichun Tong; Xiuping Zhang; Xingjun Meng; Pingyi Xu; Xiaoming Zou; Shaogang Qu
Journal:  Int J Biochem Cell Biol       Date:  2017-02-08       Impact factor: 5.085

Review 4.  Environmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity.

Authors:  A J Hannan
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

5.  Functional recovery in rats with chronic spinal cord injuries after exposure to an enriched environment.

Authors:  Florence R Fischer; Jean D Peduzzi
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

6.  Recovery of learning and memory is associated with chromatin remodelling.

Authors:  Andre Fischer; Farahnaz Sananbenesi; Xinyu Wang; Matthew Dobbin; Li-Huei Tsai
Journal:  Nature       Date:  2007-04-29       Impact factor: 49.962

Review 7.  Epigenetic memory: the Lamarckian brain.

Authors:  Andre Fischer
Journal:  EMBO J       Date:  2014-04-09       Impact factor: 11.598

8.  HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.

Authors:  Xiaolei Zhu; Sulei Wang; Linjie Yu; Jiali Jin; Xing Ye; Yi Liu; Yun Xu
Journal:  Aging Cell       Date:  2017-08-03       Impact factor: 9.304

9.  Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.

Authors:  Shaomin Li; Ming Jin; Lei Liu; Yifan Dang; Beth L Ostaszewski; Dennis J Selkoe
Journal:  Acta Neuropathol Commun       Date:  2018-11-08       Impact factor: 7.801

10.  Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome.

Authors:  Katelin F Hansen; Kensuke Sakamoto; Sydney Aten; Kaiden H Price; Jacob Loeser; Andrea M Hesse; Chloe E Page; Carl Pelz; J Simon C Arthur; Soren Impey; Karl Obrietan
Journal:  Learn Mem       Date:  2016-01-15       Impact factor: 2.699

View more
  14 in total

1.  Multisensory Stimulation Improves Cognition and Behavior in Adult Male Rats Born to LT4-treated Thyroidectomized Dams.

Authors:  Alice Batistuzzo; Guilherme G de Almeida; Tayna S Brás; Victoria P Zucato; Alexandre J T Arnold; Gisele Giannocco; Juliana M Sato; Laís M Yamanouchi; Eduardo Dias; Fernanda B Lorena; Bruna P P do Nascimento; Antonio C Bianco; Miriam O Ribeiro
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

Review 2.  MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy.

Authors:  Amir Hossein Mohammadi; Seyedvahid Seyedmoalemi; Mahsa Moghanlou; Seyed Amirreza Akhlagh; Sayyed Alireza Talaei Zavareh; Michael R Hamblin; Ameneh Jafari; Hamed Mirzaei
Journal:  Mol Neurobiol       Date:  2022-06-06       Impact factor: 5.682

Review 3.  The Molecular Effects of Environmental Enrichment on Alzheimer's Disease.

Authors:  Anthony Kin Yip Liew; Chuin Hau Teo; Tomoko Soga
Journal:  Mol Neurobiol       Date:  2022-09-09       Impact factor: 5.682

Review 4.  Histone deacetylase-3: Friend and foe of the brain.

Authors:  Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

Review 5.  Alzheimer's Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target.

Authors:  Meng Zhang; Zhigang Bian
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

6.  Dendritic Spine and Synaptic Plasticity in Alzheimer's Disease: A Focus on MicroRNA.

Authors:  Edwin Estefan Reza-Zaldivar; Mercedes Azucena Hernández-Sápiens; Benito Minjarez; Ulises Gómez-Pinedo; Victor Javier Sánchez-González; Ana Laura Márquez-Aguirre; Alejandro Arturo Canales-Aguirre
Journal:  Front Cell Dev Biol       Date:  2020-05-05

Review 7.  Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease.

Authors:  Bhanu Chandra Karisetty; Akanksha Bhatnagar; Ellen M Armour; Mariah Beaver; Haolin Zhang; Felice Elefant
Journal:  Front Mol Neurosci       Date:  2020-11-13       Impact factor: 5.639

8.  The mechanism of enriched environment repairing the learning and memory impairment in offspring of prenatal stress by regulating the expression of activity-regulated cytoskeletal-associated and insulin-like growth factor-2 in hippocampus.

Authors:  Su-Zhen Guan; You-Juan Fu; Feng Zhao; Hong-Ya Liu; Xiao-Hui Chen; Fa-Qiu Qi; Zhi-Hong Liu; Tzi Bun Ng
Journal:  Environ Health Prev Med       Date:  2021-01-15       Impact factor: 3.674

9.  AhR Ligands Differentially Regulate miRNA-132 Which Targets HMGB1 and to Control the Differentiation of Tregs and Th-17 Cells During Delayed-Type Hypersensitivity Response.

Authors:  Osama A Abdulla; Wurood Neamah; Muthanna Sultan; Saurabh Chatterjee; Narendra Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 8.786

Review 10.  The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives.

Authors:  Hannah Walgrave; Lujia Zhou; Bart De Strooper; Evgenia Salta
Journal:  Mol Neurodegener       Date:  2021-11-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.